# Assessing Physical Function in Sickle Cell Patients Taking Voxelotor

> **NCT06023199** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Inova Health Care Services** · enrollment: 6 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Voxelotor

## Key facts

- **NCT ID:** NCT06023199
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-10-23
- **Primary completion:** 2025-09-17
- **Final completion:** 2026-06-15
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06023199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06023199, "Assessing Physical Function in Sickle Cell Patients Taking Voxelotor". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06023199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*